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Abstract
Human biotin requirements are unknown and the identification of reliable markers of biotin status is necessary to fill this knowledge gap.
Here, we used an outpatient feeding protocol to create states of biotin deficiency, sufficiency and supplementation in sixteen healthy men
and women. A total of twenty possible markers of biotin status were assessed, including the abundance of biotinylated carboxylases in
lymphocytes, the expression of genes from biotin metabolism and the urinary excretion of biotin and organic acids. Only the abundance
of biotinylated 3-methylcrotonyl-CoA carboxylase (holo-MCC) and propionyl-CoA carboxylase (holo-PCC) allowed for distinguishing
biotin-deficient and biotin-sufficient individuals. The urinary excretion of biotin reliably identified biotin-supplemented subjects, but did
not distinguish between biotin-depleted and biotin-sufficient individuals. The urinary excretion of 3-hydroxyisovaleric acid detected
some biotin-deficient subjects, but produced a meaningful number of false-negative results and did not distinguish between biotin-
sufficient and biotin-supplemented individuals. None of the other organic acids that were tested were useful markers of biotin status.
Likewise, the abundance of mRNA coding for biotin transporters, holocarboxylase synthetase and biotin-dependent carboxylases in lym-
phocytes were not different among the treatment groups. Generally, datasets were characterised by variations that exceeded those seen in
studies in cell cultures. We conclude that holo-MCC and holo-PCC are the most reliable, single markers of biotin status tested in the present study.
Key words: Biotin status assessment: Carboxylases: Gene expression: Organic acids
Biotin is a water-soluble vitamin that serves as a coenzyme for
five human carboxylases, namely acetyl-CoA carboxylases
(ACC) 1 and 2, pyruvate carboxylase, propionyl-CoA carboxy-
lase (PCC) and 3-methylcrotonyl-CoA carboxylase (MCC)(1).
These enzymes play an important role in the metabolism of
fatty acids, glucose and amino acids. Histones H3 and H4
are also modified by covalent attachment of biotin(2–5). Bioti-
nylation of histones is a rare event, and less than 0·001 % of
histones H3 and H4 are biotinylated(6–8). Biotinylated histones
are over-represented in repressed loci(4,5,9) and, despite
their rarity, biotinylation marks contribute to chromatin con-
densation(10). The binding of biotin to both carboxylases
and histones is catalysed by holocarboxylase synthetase(1,11).
Despite the essential roles of biotin in intermediary metab-
olism and gene regulation, human biotin requirements are
unknown. Consequently, only recommendations for adequate
intake, but no RDA, are available for biotin(12). Recommen-
dations for adequate intake are based solely on biotin intake
in the general, apparently healthy, population(12). This
approach is flawed in the case of biotin, where dietary
intake data are only crude estimates. Currently, no studies
are available quantifying biotin in foods using chemically
specific assays(13), and it is unclear whether intake estimates
exceed or underestimate the true biotin intake. Also, the
‘normal state’ is defined using biotin-dependent enzymes or
urinary biotin metabolites as markers, while ignoring the
changes occurring at the chromatin level.
As of today, no comprehensive study has been published
that investigated markers of human biotin status from various
possible angles, including carboxylase biotinylation, metabo-
lome and transcriptome in healthy adults. The identification
of sensitive and robust markers of biotin status would rep-
resent a major advance in our pursuit of the quantification
of human biotin requirements. In the present study, we
devised a biotin feeding protocol to create states of biotin
depletion, biotin sufficiency and biotin supplementation in
healthy women and men. We assessed the suitability of
twenty distinct markers to identify those that reliably discrimi-
nate among the subjects in the three treatment groups. Only
two markers met our stringent requirements and can be
*Corresponding author: J. Zempleni, fax þ1 402 472 1587, email jzempleni2@unl.edu
Abbreviations: 3-HIA, 3-hydroxyisovaleric acid; ACC, acetyl-CoA carboxylase; HABA, 2-(40-hydroxyazobenzene)-benzoic acid; MCC, 3-methylcrotonyl-CoA
carboxylase; PCC, propionyl-CoA carboxylase.
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considered as reliable markers of biotin status. Some of the
other markers might be useful for use in future population
studies, but only if used in combination with additional
markers.
Subjects and methods
Study principle
The present study is a randomised cross-over outpatient study.
Defined states of biotin supply were established by supple-
menting the study subjects with drinks containing spray-
dried egg-white. Egg-white contains the protein avidin,
which binds biotin tightly and makes the vitamin unavailable
for intestinal absorption(14,15). Graded levels of chemically
pure biotin were added back to the egg-white shakes, thereby
inducing states of biotin depletion, biotin sufficiency and
biotin supplementation (given later).
Study subjects
A total of seventeen apparently healthy adults (seven men and
ten women) aged 21–45 years completed the present study.
Exclusion criteria included a recent history of smoking(16),
inborn errors of biotin metabolism (carboxylase deficiency,
holocarboxylase synthetase deficiency and biotinidase
deficiency)(17,18), use of vitamin supplements, use of anticon-
vulsants(19,20), pregnancy(21,22) and lactation(12,23). Women
were tested for pregnancy prior to each period of egg-white
feeding by using a commercial pregnancy test. Subjects were
allowed to engage in normal daily activities. After the end of
the study, one male subject (21 years old) admitted that he
did not comply with the study protocol and his data were
excluded from the analysis. During the biotin-deficient
phase, none of the subjects had frank signs of severe biotin
deficiency such as dermatitis, rash and alopecia. The present
study was conducted according to the guidelines laid down
in the Declaration of Helsinki, and all procedures involving
human subjects were approved by the Institutional Review
Board of the University of Nebraska-Lincoln, USA. Subjects
signed an informed consent prior to enrolling in the study.
Study protocol
The entire study took each subject 15 weeks to complete
(Fig. 1). During the first 2 weeks, subjects consumed a regular,
self-selected diet without the use of any vitamin supplements.
The objective of this adjustment period was to eliminate
excess vitamins from inadvertent use of vitamin supplements
before the study began. Subjects were instructed to avoid
biotin-rich foods such as yeast, livers, meats, cereals,
mayonnaise and eggs(24), and were provided with a list of
foods to avoid. After completion of the adjustment period,
each subject completed the following three treatment phases
(3 weeks each)(25) in randomised order: biotin depletion
(zero dietary biotin, representing levels seen in individuals
consuming diets containing raw egg-white and individuals
with undiagnosed deficiencies of biotinidase)(26,27), biotin suf-
ficiency (30mg/d, representing recommendations for adequate
intake of biotin)(12) and biotin supplementation (600mg/d,
representing the level of biotin in typical over-the-counter
supplement users)(28,29). In the second week of each treat-
ment, participants filled out 3-d dietary records in order to esti-
mate biotin intake. Periods of biotin-defined diets were
interrupted by 2 weeks with no biotin treatment. These
periods are sufficiently long for biotin levels to return to base-
line level(15,25,30). Subjects consumed a regular, self-selected
diet (given earlier), modified only by the amounts of biotin
during treatment phases.
During treatment, dietary biotin was adjusted by consuming
an egg-white drink (200 ml) with every major meal (breakfast,
lunch and dinner) of the day. The amount of egg-white in the
drinks was chosen as follows. First, the amount of avidin in
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Fig. 2. (A) Abundance of biotinylated (holo-)pyruvate carboxylase (PC),
3-methylcrotonyl-CoA carboxylase (MCC) and propionyl-CoA carboxylase
(PCC) in lymphocytes from biotin-deficient (DEF), biotin-sufficient (SUF) and
biotin-supplemented (SUP) healthy adults (top gel). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as the loading control (bottom
gel). The image was cropped from an original full-size scanned picture. (B) Gel
densitometry analysis of holo-MCC (n 16, 0·0003 , P,0·0012 with Bonferroni
correction for all possible comparisons). (C) Gel densitometry analysis of holo-
PCC (n 16, P,0·0003 with Bonferroni correction for all possible comparisons).
Values are means, with standard deviations represented by vertical bars.
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spray-dried egg-white (Barry Farm, Cridersville, OH, USA) was
titrated based on the 2-(40-hydroxyazobenzene)-benzoic acid
(HABA) assay (n 8)(31,32). Avidin activity (mg/ml dried egg-
white) was calculated based on the method of Green(31,32)
using the following equation:
AA ¼ ð3·1 £ 68 000 £OD £ 1000Þ=ð3 £ 34 000 £ 4Þ;
where AA is avidin activity (mg/ml dried egg-white), 3·1 is the
sample volume (ml) after the addition of HABA, 68 000 mol-
ecular weight of avidin, OD is optical density of the super-
natant of the egg-white solution plus HABA at 500 nm
corrected by the optical density before HABA, 3 is the
sample volume (ml) before the addition of HABA and 4 is
the number of avidin molecules in the avidin tetramer.
A measure of 1 g of egg-white contained approximately
600mg of avidin. Second, we calculated the amount of
egg-white needed to bind the biotin in an average diet
(30–70mg/d)(12), including an allowance for microbial biotin
synthesis and diets that were inadvertently high in biotin.
Assuming that 1mg of avidin binds 0·014mg biotin(32), we pre-
pared egg-white drinks containing 7·1 mg of avidin in 200 ml
(one serving), which is sufficient to bind about 100mg of
biotin. Spray-dried egg-white was dissolved in orange juice
to improve palatability; the juices were stored at 48C for up
to 2 d before consumption. This drink was used for depleting
subjects of biotin. For biotin-sufficient subjects, biotin was
added back to the drinks to saturate all the avidin plus provide
an additional 30mg/d. For biotin-supplemented subjects, the
amount of available biotin was adjusted to 600mg/d. Our esti-
mates were confirmed by quantifying the content of free
biotin in egg-white drinks by using the avidin-binding assay(29).
Sample collection
Blood samples were collected after an overnight fast by an
experienced phlebotomist at the University Health Center of
Nebraska-Lincoln. A volume of 180 ml of fasting blood was
collected after the initial 2-week adjustment period and on
the last day of each treatment period. In addition, 30 ml of fast-
ing blood were collected after the 2-week washout period of
each treatment. Lymphocytes were isolated by density gradi-
ent centrifugation and counted using a haemocytometer(33).
Aliquots of twenty million and two million cells were frozen
(2808C) for subsequent carboxylase analysis and for isolation
of total RNA, respectively. Spot urine samples were collected
after an overnight fast at the end of each washout and treat-
ment phase. Urine samples were sub-aliquoted to avoid
repeated freeze–thaw cycles and frozen at 2208C for the sub-
sequent analyses of organic acids, biotin and creatinine.
Sample analysis
The abundance of biotinylated (holo-)carboxylases was
quantified in lymphocyte extracts as described(30), using
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Fig. 3. Abundance of mRNA coding for (A) sodium-dependent multivitamin transporter (SMVT), (B) monocarboxylate transporter 1 (MCT1), (C) 3-methylcrotonyl-
CoA carboxylase b (MCCb), (D) acetyl-CoA carboxylase 1 (ACC1) and (E) holocarboxylase synthetase (HLCS) in lymphocytes from biotin-deficient (DEF),
biotin-sufficient (SUF) and biotin-supplemented (SUP) healthy adults. Values are means, with standard deviations represented by vertical bars
(n 16, 0·0784 , P,0·9823).
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20mg of protein and 3–8 % Tris–acetate gels (Invitrogen).
Holocarboxylase-bound biotin in transblots was probed with
fluorophore-labelled streptavidin; glyceraldehyde-3-phosphate
dehydrogenase was used as a loading control(4). The mem-
brane was scanned using the 800CW channel in an IR imaging
system (Odyssey LI-COR) and band intensities were quantified
by gel densitometry(30).
Total RNA was extracted from lymphocytes using the
ZR RNA MicroPrep (Zymo Research) following the manufacturer’s
instructions. RNA was reverse transcribed into complementary
DNA using the High Capacity RNA-to-cDNA Kit (Applied
Biosystems), following the manufacturer’s instructions.
The abundance of mRNA coding for the Na-dependent multi-
vitamin transporter, monocarboxylate transporter 1, holocar-
boxylase synthetase, ACC1 and MCC (b bchain) were
quantified by quantitative real-time PCR using Quanta Perfecta
Power SYBR Green and the cycle threshold method(4,34). The
abundance of GAPDH mRNA was used to normalise data for
the efficiency of PCR. PCR primers were the same as reported
previously(30). Our rationale for focusing on these five genes
was that they play a role in biotin metabolism(1) and because
their expression depended on biotin in previous studies in
human cell cultures(30).
Concentrations of biotin in urine samples were quantified
by the avidin-binding assay, as described(29). As urine was
collected as a spot urine sample (as opposed to 24-h collec-
tions), urinary biotin was normalised by the excretion of creati-
nine to account for possible incomplete collections and dilution
effects. Creatinine was quantified using the standard picric acid
method of Jaffe(35). Concentrations of urinary organic acids
were determined by a capillary electrophoresis method in our
laboratory. Briefly, urine samples were thawed and centrifuged
at 16 100 g for 1 min. A volume of 100ml of supernatant was lyo-
philised and weights of the freeze-dried samples were recorded
for data normalisation. After being re-dissolved in 50ml of nano-
pure water, samples were injected into a 50 cm bare fused-silica
capillary (inner diameter 50mm) under the pressure of 0·5 psi
(pounds per square inch) for 5 s. Various organic acids were
resolved at 15 kVand 258C using a Beckman P/ACE MDQ capil-
lary electrophoresis system (Beckman Coulter) equipped with a
200 nm UV filter using 250 mM-phosphate buffer (pH 6·0) with
0·1 mM-hexadecyltrimethylammonium bromide and 5 % metha-
nol (by vol.). Authentic standards of organic acid were pur-
chased from Sigma-Aldrich. The following nine organic acids
were quantified by a standard curve method and their urinary
excretion was normalised by the excretion of creatinine: acet-
ate, a-ketoglutarate, butyrate, citrate, fumarate, malate, oxalate,
succinate and 3-hydroxyisovaleric acid (3-HIA). Our rationale
for focusing on these organic acids was that they are implicated
in biotin-dependent pathways in intermediary metabolism and
that, for some of them, links have been established with biotin
deficiency(1,36).
Statistical analysis
To test for homogeneity of variances, Barlett’s test or Levene’s
test was performed(37). Data were log transformed if variances
were heterogeneous; log transformation resulted in homogeneous
variances. The significance of differences among groups was
tested with one-way ANOVA and the Bonferroni method
was used to adjust for multiple comparisons where appropri-
ate(37). StatView 5.0.1 (SAS Institute) was used to perform all
calculations. Differences are considered significant if
P,0·05. Data are expressed as mean and standard deviations,
where SD represents sample standard deviation in all cases.
Results
Holocarboxylases
Biotinylated holo-MCC (molecular mass ¼ 83 kDa) and
holo-PCC (molecular mass ¼ 80 kDa) from lymphocyte
extracts were easily detectable in streptavidin blots and
appear to be reliable markers for biotin status (Fig. 2(A)).
Note that streptavidin blotting detects the biotinylated
a-chains of these carboxylases, but not the non-biotinylated
b-chains. While the abundance of holo-pyruvate carboxylase
also appeared to respond to dietary biotin, the signal pro-
duced by holo-pyruvate carboxylase was faint and hard to
detect, suggesting that pyruvate carboxylase might not be a
good marker for biotin status. Holo-ACC1 and ACC2 were
not detectable in streptavidin blots of lymphocyte extracts,
which is consistent with previous studies in human lymphoid
cell cultures(29). Gels were equally loaded, judged by the
abundance of the housekeeping protein glyceraldehyde-
3-phosphate dehydrogenase.
Gel densitometry analysis of holo-MCC and holo-PCC is
consistent with the notion that these proteins are good
markers for biotin status. The abundance of holo-MCC
(arbitrary units) was 4·1 (SD 2·6) in biotin-depleted subjects,
8·2 (SD 3·5) in biotin-sufficient subjects and 15·7 (SD 7·5)
in biotin-supplemented subjects (0·0003 , P,0·0012 with
Bonferroni correction for all possible comparisons, n 16,
Fig. 2(B)). Likewise, the abundance of holo-PCC (arbitrary
units) was 4·1 (SD 1·9) in biotin-depleted subjects, 9·1
(SD 3·3) in biotin-sufficient subjects and 17·0 (SD 5·7) in
biotin-supplemented subjects (P,0·0003 with Bonferroni
correction for all possible comparisons, n 16, Fig. 2(C)).
Real-time PCR
The abundance of mRNA coding for the biotin transporters,
Na-dependent multivitamin transporter and monocarboxylate
transporter 1; the biotin-dependent carboxylases, ACC1 and
Table 1. Urinary excretion of biotin in the three treatment groups (n 16)
(Mean values and standard deviations)
Urinary biotin
(nmol biotin/mmol creatinine)
Treatment Mean SD
Biotin deficient 0·52a 1·19
Biotin sufficient 0·74a 1·13
Biotin supplemented 2·54b 2·01
a,b Mean values with unlike superscript letters were significantly different
(0·0001 , P,0·16).
W. K. Eng et al.324
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MCC (b-chain); and holocarboxylase synthetase was not
significantly different among the treatment groups (Fig. 3),
contrary to previous observations in human cell cultures(30).
This apparent absence of effect can largely be explained
by the large inter-individual variations among subjects.
When men and women were analysed separately, the results
were the same as for the pooled dataset (data not shown).
We conclude that the abundance of mRNA coding for genes
in biotin metabolism is not a good marker of biotin status in
outpatient studies.
Excretion of biotin in urine
The urinary excretion of biotin was up to five times higher in
biotin-supplemented subjects compared with the other treat-
ment groups (Table 1). There was a trend towards higher urin-
ary biotin in biotin-sufficient individuals compared with
biotin-depleted individuals, but the difference was not statisti-
cally significant. This apparent absence of effect can largely be
explained by the large inter-individual variations among sub-
jects. When men and women were analysed separately, the
results were the same as for the pooled dataset (data not
shown). We conclude that the urinary excretion of biotin is
a good marker for identifying supplement users, but is not a
good marker to distinguish deficient from sufficient individ-
uals in outpatient studies.
Excretion of organic acids in urine
The urinary excretion of 3-HIA was, on average, two times
higher in biotin-deficient subjects compared with the other
treatment groups (Fig. 4(A)). The use of 3-HIA as a marker
of biotin status is limited by the following characteristics.
First, the excretion of 3-HIA does not distinguish biotin-
sufficient and biotin-supplemented subjects. Second, for
eight of the sixteen subjects, the urinary excretion of 3-HIA
did not increase during biotin depletion compared with
other phases (Fig. 4(B)), suggesting that the urinary excretion
of 3-HIA has a tendency to produce false negatives in
biotin-deficient subjects. For clarity, we show values only for
those eight subjects for whom urinary 3-HIA did not respond
to dietary biotin; for comparison, the figure also includes the
data for one subject that showed the expected pattern of a
higher excretion of 3-HIA during biotin depletion compared
with other phases. When men and women were analysed sep-
arately, the results were the same as for the pooled dataset
(data not shown).
Two of the remaining organic acids produced potentially
interesting trends regarding their urinary patterns, although
effects did not reach a statistically significant level. Urinary
citrate was positively linked with biotin intake (Fig. 5(A)),
while urinary malate was negatively linked with biotin
intake (Fig. 5(B)), but none of these organic acids produced
statistically significant effects due to large inter-individual
variation. Results were the same when men and women
were analysed separately. The urinary excretion of acetate,
a-ketoglutarate, butyrate, fumarate, oxalate and succinate
did not depend on biotin intake.
Dietary records
The dietary intake of biotin was of the expected magnitude
and well within the amount that can be bound by the avidin
in the egg-white drinks. The intake of biotin over a 3-d
period was 37·9 (SD 23·5)mg in biotin-depleted subjects, 65·2
(SD 71·4)mg in biotin-sufficient subjects and 49·3 (SD 29·2)mg
in biotin-supplemented subjects (n 16), excluding the biotin
that was added back to drinks. These values should be con-
sidered as crude estimates because there is currently no data-
base that accurately quantifies biotin in foods(38,39). Despite
the limited accuracy of existing databases, the intake estimates
reported here are consistent with the notion that subjects
avoided foods rich in biotin throughout the study.
Efficacy of washout
Adjustment and washout periods were chosen to be suffi-
ciently long to allow for biotin levels to return to baseline
levels. When carboxylase-bound biotin in lymphocyte extracts
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Fig. 4. (A) Average urinary excretion of 3-hydroxyisovaleric acid (3-HIA) in biotin-deficient (DEF), biotin-sufficient (SUF) and biotin-supplemented (SUP) healthy
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was probed with streptavidin, no apparent difference among
the various phases was detected for any of the study subjects.
Fig. 6 depicts the raw data from one subject as a representative
example. The abundance of glyceraldehyde-3-phosphate
dehydrogenase was used as a loading control. Likewise, the
urinary excretion of biotin returned to baseline levels by the
end of each washout period (approximately 1 nmol biotin/
mmol creatinine, assayed in randomly selected samples).
Discussion
The present paper is the first study that uses an outpatient
feeding protocol in normal healthy adults to assess the effects
of deficiency, sufficiency and supplementation of biotin on a
comprehensive set of twenty variables from proteomics, tran-
scriptomics and metabolomics. The study provides compelling
evidence that the abundance of biotinylated (holo-)MCC and
PCC in lymphocytes are the only markers that can reliably dis-
criminate between states of moderate biotin deficiency and
biotin sufficiency. This observation is consistent with previous
studies in human lymphoid cell cultures, which also suggest
that biotinylation of MCC and PCC is responsive to biotin
intake(29,30). Greater than 50 % of PCC in lymphocytes from
biotin-depleted individuals is present in the biotin-free apo-
form, based on ex vitro cultures of lymphocytes from patients
on biotin-free nutrition(40). Previous studies in healthy
adults(41) and rats(42) also led to the conclusion that the activity
of PCC is a good marker of biotin status in the population.
Those studies used the incorporation of radiolabelled bicar-
bonate for assessing carboxylase activity, while in the present
study we quantified the binding of biotin to carboxylases. In
previous studies, we demonstrated that both carboxylase
activity and carboxylase biotinylation correlate well(29).
However, we believe that the dependence on radiolabelled
compounds is a meaningful limitation when using carboxy-
lases as markers for biotin status. We also believe that strepta-
vidin blots of carboxylases has the additional advantage of
assessing multiple carboxylases in one single run, while
activity assays require distinct analytical procedures for each
of these enzymes(43).
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When biotin is insufficient during leucine metabolism, it
shunts the pathway to an alternative pathway, leading to the
formation of 3-HIA(1). Urinary 3-HIA is generally considered
a useful marker for biotin status(36,44,45). Based on the findings
in the present study, the usefulness of 3-HIA as a marker of
biotin status needs to be re-evaluated because of the following
concerns. First, urinary 3-HIA does not permit discriminating
biotin-sufficient and biotin-supplemented individuals.
Second, the average urinary excretion of 3-HIA was greater
in biotin-deficient subjects compared with other treatment
groups, but produced a meaningful number of false-negative
results when looking at the individuals in the biotin-deficient
group. More recently, carnitine conjugates of 3-HIA have
been recommended as markers of biotin status(45–47). Carni-
tine conjugates of 3-HIA were not tested in the present
study, but might be a useful alternative to free 3-HIA. When
validating carnitine conjugates in future studies, great care
should be taken (a) to document inter-individual variation,
(b) to test for false negatives in a population of biotin-depleted
individuals and (c) to determine whether these conjugates dis-
criminate between sufficient and supplemented individuals.
Some variables such as organic acids produced borderline
significant changes of some markers in response to biotin
intake. One could argue that these variables may produce stat-
istically significant results if tested in a sample larger than six-
teen subjects. Such concerns are formally correct. However,
concerns would remain as to whether such variables are
useful markers when trying to single out individuals with
slightly lower and slightly higher biotin intake compared
with the average intake in the sample.
One could consider using urinary biotin as a marker of
biotin status. Our studies suggest that the urinary excretion
of biotin reliably identifies biotin-supplemented subjects, but
does not distinguish between biotin-depleted and biotin-
sufficient individuals. Also, urine contains biotin metabolites
suchasbisnorbiotin, biotin-D,L-sulphoxides,biotin sulphone,bis-
norbiotin methyl ketone and tetranorbiotin-L-sulphoxide(48,49).
Typical biotin assays do not quantify these metabolites accu-
rately, and their analysis is reserved for specialty laboratories.
Serum biotin concentration and biotinidase activity were not
measured in the present study, based on the following lines of
reasoning. Previous studies suggest that serum concentrations
of biotin and biotin metabolites do not decrease in biotin-
deficient individuals(50) and in patients on biotin-free total
parenteral nutrition(40) during reasonable periods of obser-
vation. Previous studies also suggest that the expression of
biotinidase does not depend on biotin in human cell
cultures(30).
Of the twenty potential markers of biotin status that were
tested in the present study, quantification of mRNA abundance
returned the least compelling results. None of the five genes
from biotin turnover was linked in any way to biotin intake.
This can be attributed to large inter-individual variations in
the expression of these genes. This observation is in striking
contrast to studies in cell cultures and laboratory animals,
where the expression of these genes depended on
biotin(30,51,52). We propose that the genetic diversity in
human subjects and environmental factors create a unique
scenario, and the studies in cell cultures and inbred animals
need to be interpreted with care.
Collectively, we conclude that the number of reliable mar-
kers of biotin status is limited and that more groundwork
needs to be done before human biotin requirements can be
quantified with a reasonable level of certainty. No single
marker is currently known that reliably distinguishes moder-
ately biotin-deficient, biotin-sufficient and moderately biotin-
supplemented individuals.
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